2020
DOI: 10.1111/jpc.15148
|View full text |Cite
|
Sign up to set email alerts
|

De novoSEC61A1 mutation in autosomal dominant tubulo‐interstitial kidney disease: Phenotype expansion and review of literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 9 publications
(19 reference statements)
0
8
0
Order By: Relevance
“…The heterozygous SEC61A1 alleles identified in humans include four missense mutations causing the amino acid substitutions V67G (plug domain), V85D (pore ring residue, TMH 2), Q92R (TMH 2), and T185A (TMH 5) as well as one nonsense mutation introducing a premature stop at E381* (TMH 8). The rare-diseases arising from those mutations are (i) common variable immunodeficiency for V85D and E381* ( Schubert et al, 2017 ), (ii) autosomal dominant severe congenital neutropenia for V67G ( Bolar et al, 2016 ) and Q92R ( Van Nieuwenhove et al, 2020 ), and (iii) autosomal dominant tubulointerstitial kidney disease (ADTKD) for V67G and T185A ( Bolar et al, 2016 ; Espino-Hernández et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…The heterozygous SEC61A1 alleles identified in humans include four missense mutations causing the amino acid substitutions V67G (plug domain), V85D (pore ring residue, TMH 2), Q92R (TMH 2), and T185A (TMH 5) as well as one nonsense mutation introducing a premature stop at E381* (TMH 8). The rare-diseases arising from those mutations are (i) common variable immunodeficiency for V85D and E381* ( Schubert et al, 2017 ), (ii) autosomal dominant severe congenital neutropenia for V67G ( Bolar et al, 2016 ) and Q92R ( Van Nieuwenhove et al, 2020 ), and (iii) autosomal dominant tubulointerstitial kidney disease (ADTKD) for V67G and T185A ( Bolar et al, 2016 ; Espino-Hernández et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…Mammalian cells, which are highly active in protein secretion, termed professional secretory cells, may be particularly sensitive towards problems in Sec61 channel closure and, therefore, constantly on the verge to apoptosis. This has recently been seen in human patients associated with dominant negative effects in the course of i) autosomal dominant tubulointerstitial kidney disease (ADTKD) and glomerulocystic kidney disease in kidney cells with the Sec61α 1V67G- or Sec61α 1T185A-exchanges [ 256 , 257 ], ii) hypogammaglobulinemia or primary antibody deficiency (PAD) in plasma cells with the Sec61α 1V85D exchange [ 258 ], plus iii) autosomal dominant severe congenital neutropenia (ADSCN) in neutrophils with the Sec61α 1V67G- or Sec61α 1Q92R-exchanges [ 256 , 259 ] and associated with Diabetes mellitus for the β-cells of the mouse with the homozygous Sec61α1Y344H exchange [ 260 ]. The fact that ERj6 (DNAJC3) is involved in Sec61 channel closure and that its absence in human patients, too, causes Diabetes mellitus is in perfect line with this interpretation [ 261 ].…”
Section: Sec61-channelopathiesmentioning
confidence: 99%
“…In three independent families with seven, two and one patient(s), respectively, suffering from autosomal dominant tubulointerstitial kidney disease (ADTKD) and glomerulocystic kidney disease with congenital anemia, respectively, heterozygous SEC61A1 mutations were identified. These are two missense mutations causing the amino acid substitutions V67G (in the plug helix) and T185A (near the pore ring in TMH 5), respectively [ 256 , 257 ]. The T185A mutation caused ADTKD with a more severe and complex tubular phenotype.…”
Section: Sec61-channelopathiesmentioning
confidence: 99%
“…The total loss or reduced abundance of tissue-specific proteins could also cause or contribute to a localized disease phenotype. As is the case of the widely present Sec61α protein, the majority of analyzed Sec61α point mutations result in distinct pathological phenotypes in different organs or tissues and eventually reflect the substrate-specific requirements found in the affected body part [ 276 , 283 , 404 , 438 , 439 ].…”
Section: Disease-causing Mutations Of Targeting and Translocation Componentsmentioning
confidence: 99%